Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-04 10:43 am Sale | 2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | SABBY MANAGEMENT LLC | 260,928 11.000% | -985,317 (-79.06%) | Filing History |
| 2021-11-04 07:38 am Purchase | 2021-10-27 | 13D | PharmaCyte Biotech, Inc. PMCB | Iroquois Capital Management, LLC | 1,048,646 5.100% | 1,048,646 (New Position) | Filing History |
| 2021-08-30 08:30 am Purchase | 2021-08-27 | 13G | PharmaCyte Biotech, Inc. PMCB | SABBY MANAGEMENT LLC | 1,246,245 11.000% | 1,246,245 (New Position) | Filing History |
| 2021-08-30 06:31 am Purchase | 2021-08-19 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 1,063,210 6.300% | 1,063,210 (New Position) | Filing History |